RESUMO
In France, there have been variations in the incidence of invasive meningococcal infection due to serogroup C isolates. Infection peaks were observed in 1992 and 2003 that involved isolates of phenotypes C:2a:P1.5,2 and/or C:2a:P1.5, which belong to the sequence type 11 (ST-11) clonal complex. We report an emergence of isolates belonging to the ST-11 clonal complex since 2003. These isolates displayed a new phenotype, C:2a:P1.7,1, caused infections that occurred as clusters, and were associated with increased infection severity and high virulence in mice. These isolates may be responsible for a peak in the incidence of serogroup C meningococcal infection in France, for which there is no routine vaccination to date.
Assuntos
Meningite Meningocócica/epidemiologia , Infecções Meningocócicas/epidemiologia , Neisseria meningitidis/genética , Neisseria meningitidis/patogenicidade , Animais , Vacinas Bacterianas/uso terapêutico , Ensaio de Unidades Formadoras de Colônias , Modelos Animais de Doenças , Surtos de Doenças/estatística & dados numéricos , Ensaio de Imunoadsorção Enzimática , França/epidemiologia , Humanos , Meningite Meningocócica/imunologia , Camundongos , Camundongos Transgênicos , Neisseria meningitidis/classificação , Neisseria meningitidis/isolamento & purificação , Fenótipo , Transferrina/genéticaRESUMO
The underlying mechanisms of the epidemiological association between influenza virus infections and Neisseria meningitidis invasive infections are not fully understood. Here we report that adhesion of N. meningitidis to human Hec-1-B epithelial cells is enhanced by influenza A virus (IAV) infection. A potential role of the viral neuraminidase (NA) in facilitating meningococcal adhesion to influenza virus-infected epithelial cells was examined. Expression of a recombinant IAV NA in Hec-1-B human epithelial cells increased the adhesion of strains of N. meningitidis belonging to the sialic acid-containing capsular serogroups B, C, and W135 but not to the mannosamine phosphate-containing capsular serogroup A. Adhesion enhancement was not observed with an inactive NA mutant or in the presence of an NA inhibitor (zanamivir). Furthermore, purified IAV NA was shown to cleave sialic acid-containing capsular polysaccharides of N. meningitidis. On the whole, our findings suggest that a direct interaction between the NA of IAV and the capsule of N. meningitidis enhances bacterial adhesion to cultured epithelial cells, most likely through cleavage of capsular sialic acid-containing polysaccharides. A better understanding of the association between IAV and invasive meningococcal infections should help to set up improved control strategies against these seasonal dual viral-bacterial infections.
Assuntos
Aderência Bacteriana , Cápsulas Bacterianas/fisiologia , Vírus da Influenza A Subtipo H1N1/fisiologia , Vírus da Influenza A Subtipo H3N2/fisiologia , Neisseria meningitidis/fisiologia , Neuraminidase/fisiologia , Ácidos Siálicos/fisiologia , Linhagem Celular Tumoral , Células Epiteliais/microbiologia , Humanos , Neuraminidase/genéticaRESUMO
The management of acute bacterial meningitis is based on early antibiotic treatment to prevent unfavorable outcome (death and permanent sequelae). beta-Lactam antibiotics, particularly third-generation cephalosporins, are effective against most agents of community-acquired acute bacterial meningitis. Resistance to beta-lactams evolves, particularly in Streptococcus pneumoniae, that may lead to treatment failure. Evaluation of other antibiotics such as fourth-generation cephalosporin, new penems and quinolones is warranted. Adjunctive therapy aims to reduce tissue injuries provoked by the inflammatory response. The use of dexamethasone is still a matter of debate, but seems to be helpful under conditions of rapid etiological diagnosis and prompt management. Other drugs that neutralize bacterial factors or host mechanisms involved in induction of inflammatory response are under development.
Assuntos
Antibacterianos/uso terapêutico , Meningites Bacterianas/tratamento farmacológico , Doença Aguda , Animais , Anti-Inflamatórios/uso terapêutico , Encéfalo/patologia , Citocinas/antagonistas & inibidores , Citocinas/biossíntese , Países em Desenvolvimento , Indústria Farmacêutica , Humanos , Meningites Bacterianas/complicações , Meningites Bacterianas/microbiologia , Meningites Bacterianas/patologiaRESUMO
Current anti-meningococcal vaccines are prepared from capsular saccharides (plain or conjugate). They target four serogroups A, C, Y and W135. No vaccine is available against serogroup B saccharide. However, protein-based vaccines (recombinant vaccines or outer membrane vesicle vaccines) allow developing vaccines against serogroup B isolates.
Assuntos
Meningite Meningocócica/prevenção & controle , Vacinas Meningocócicas , Neisseria meningitidis/imunologia , Desenho de Fármacos , Humanos , SorotipagemRESUMO
The pathogenesis of meningococcal disease is poorly understood due to the lack of a relevant animal model. Moreover, the use of animal models is not optimal as most meningococcal virulence determinants recognize receptors that are specifically expressed in human tissues. One major element of the host specificity is the system of meningococcal iron uptake by transferrin-binding proteins that bind specifically human transferrin but not murine transferrin. We developed a new mouse model for experimental meningococcal infection using transgenic mice expressing human transferrin. Intraperitoneal challenge of transgenic mice induced bacteremia for at least 48 h with an early stage of multiplication, whereas the initial inoculum was rapidly cleared from blood in wild-type mice. Inflammation in the subarachnoidal space with a high influx of polymorphonuclear cells was observed only in transgenic mice. Meningococcal mutants that were unable to use transferrin as a source of iron were rapidly cleared from both wild-type and transgenic mice. Thus, transgenic mice expressing human transferrin may represent an important advance as a new mouse model for in vivo studies of meningococcal virulence and immunogenicity factors.
Assuntos
Modelos Animais de Doenças , Infecções Meningocócicas/metabolismo , Neisseria meningitidis Sorogrupo C/crescimento & desenvolvimento , Transferrina/biossíntese , Administração Intranasal , Animais , Feminino , Humanos , Infusões Parenterais , Ferro/sangue , Ferro/química , Ferro/metabolismo , Infecções Meningocócicas/genética , Infecções Meningocócicas/microbiologia , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Transferrina/genéticaRESUMO
We evaluated the antimicrobial effect of antimicrobial peptides from frog skin belonging to the dermaseptin family against reference and clinical Neisseria gonorrhoeae strains, including penicillin-resistant strains. Dermaseptin S4 exhibited anti-N. gonorrhoeae activity against all strains with MICs ranging between 10 and 100 microg/mL. We then used derivatives of DS4 and determined the anti-N. gonorrhoeae activity of each of analogs. All the derivatives showed antimicrobial activity. Among the different molecules tested, we found that dermaseptins K4S4 (1-16)a and K4S4 (1-28) were the more potent to inhibit N. gonorrhoeae growth with MIC of 10 microg/mL against all strains.
Assuntos
Proteínas de Anfíbios/farmacologia , Anti-Infecciosos/farmacologia , Peptídeos Catiônicos Antimicrobianos/farmacologia , Neisseria gonorrhoeae/efeitos dos fármacos , Fragmentos de Peptídeos/farmacologia , Sequência de Aminoácidos , Peptídeos Catiônicos Antimicrobianos/síntese química , Humanos , Testes de Sensibilidade Microbiana , Dados de Sequência Molecular , Fragmentos de Peptídeos/síntese química , Peptídeos/síntese químicaRESUMO
BACKGROUND: During the period 2001-2002, Burkina Faso reported its first meningitis epidemic due to Neisseria meningitidis (Nm) serogroup W135, prompting concerns that this serogroup would persist as a cause of epidemic disease. METHODS: During the period 2002-2005, hospital- and population-based surveillances were conducted in 3 districts in Burkina Faso. Etiology was determined by culture, polymerase chain reaction (PCR), and latex agglutination. Reference laboratories determined phenotype and genotype. RESULTS: Of 2004 subjects who received a lumbar puncture, 265 were identified as having Nm, including 93 who had Nm serogroup A (NmA) and 146 who had Nm serogroup W135 (NmW135). Over the study period, the proportion of cases due to NmW135 decreased by >75%, primarily because of decreased occurrence among young children and in a single district. During peak epidemic months, the annualized incidence of NmW135 decreased from 146 cases to <1 case per 100,000 population. All but 2 NmW135 isolates were phenotype W135:2a:P1.5,2 (sequence type [ST]-11 clonal complex). All NmA isolates were phenotype A:4:P1-9 (ST-2859 of the ST-5 clonal complex). We identified 1 isolate from serogroup Y (ST-11 clonal complex), 1 isolate from serogroup X that was similar to strains previously associated with epidemic disease, and 1 isolate from serogroup W135 of the newly described ST-4375 complex. CONCLUSIONS: For unknown reasons, serogroup W135 achieved epidemic status, primarily among young children, and then largely disappeared over a short time period. The continued circulation of multiple strains with epidemic potential emphasizes the need for ongoing surveillance and the potential benefit of vaccines that are protective across serogroups.
Assuntos
Meningite Meningocócica/epidemiologia , Neisseria meningitidis Sorogrupo W-135/isolamento & purificação , Adolescente , Adulto , Burkina Faso/epidemiologia , Criança , Pré-Escolar , Surtos de Doenças , Humanos , Lactente , Meningite Meningocócica/prevenção & controle , Vacinas Meningocócicas/administração & dosagem , Neisseria meningitidis Sorogrupo W-135/classificação , SorotipagemRESUMO
Capsule switching in Neisseria meningitidis is thought to occur by horizontal DNA exchange between meningococcal strains. Antigenic variants may be generated by allelic replacement of the siaD gene; the variants may then be selected by specific immunity against the capsular antigen. There were several vaccination campaigns against serogroup C in France in 2002, following an increase in the prevalence of invasive isolates of serogroup C of the phenotype C:2a:P1.5 and C:2a:P1.5,2 belonging to the ET-37/ST-11 clonal complex. We evaluated the emergence of capsule variants by the detection of B:2a:P1.5 and B:2a:P1.5,2 meningococcal isolates of the ET-37/ST-11 clonal complex. These isolates were significantly more frequent after the year 2002. Pulsed field gel electrophoresis profiles of the serogroup B (ET-37/ST-11) isolates differed from that of serogroup C (ET-37/ST-11) isolates by the bands that harbor the siaD genes responsible for the serogroup specificity. However, serogroup B and C, ET37/ST-11 isolates both express similar virulence as assessed from colonization and invasiveness in a mouse model. Our results indicate that capsule switching events within the same clonal complex can arise frequently with no alteration in virulence. This justifies an enhanced system of surveillance by molecular typing of such isolates, particularly after serogroup-specific vaccination.
Assuntos
Cápsulas Bacterianas/metabolismo , Neisseria meningitidis/isolamento & purificação , Neisseria meningitidis/patogenicidade , Adolescente , Adulto , Idoso , Animais , Antígenos de Bactérias/genética , Antígenos de Bactérias/metabolismo , Cápsulas Bacterianas/genética , Criança , Pré-Escolar , Feminino , França/epidemiologia , Regulação Bacteriana da Expressão Gênica , Genótipo , Humanos , Lactente , Masculino , Infecções Meningocócicas/epidemiologia , Infecções Meningocócicas/microbiologia , Infecções Meningocócicas/prevenção & controle , Vacinas Meningocócicas/uso terapêutico , Camundongos , Camundongos Endogâmicos BALB C , Neisseria meningitidis/genética , Fenótipo , Fatores de Tempo , VirulênciaRESUMO
Neisseria meningitidis is a commensal bacterium of the human nasopharynx that occasionally provokes invasive disease. Carriage strains of N. meningitidis are heterogeneous, more frequent in nature and are transmitted among carriers. Disease is not a part of this transmission cycle and is caused by virulent strains. N. meningitidis is highly variable and variants that are modified in their virulence and/or transmissibility are continually generated. These events probably occur frequently, thus explaining not only the heterogeneous nature of meningococcal populations in carriers but probably also the evolutionary success of this human-restricted bacterium.
Assuntos
Portador Sadio/microbiologia , Infecções Meningocócicas/transmissão , Neisseria meningitidis/genética , Neisseria meningitidis/patogenicidade , Variação Genética , Humanos , Infecções Meningocócicas/microbiologia , Infecções Meningocócicas/fisiopatologia , Nasofaringe/microbiologia , Neisseria meningitidis/classificação , Virulência/genéticaRESUMO
From January 2001 through December 2003, a total of 1084 children with bacterial meningitis were enrolled in a prospective French nationwide survey. The most frequent pathogens found in children older than 28 days were Neisseria meningitis (55.3%) and Streptococcus pneumoniae (33.4%). S. pneumoniae was the most frequent pathogen found among infants aged 2-12 months (49.5%), whereas N. meningitidis was the most frequent pathogen among children >12 months old (69.7%). Approximately one-half of S. pneumoniae isolates had diminished susceptibility to penicillin. The case-fatality rates were 7.6% for children with N. meningitidis meningitis and 10.8% for children with S. pneumoniae infection.
Assuntos
Meningites Bacterianas/epidemiologia , Adolescente , Distribuição por Idade , Criança , Pré-Escolar , França/epidemiologia , Humanos , Lactente , Meningites Bacterianas/microbiologiaRESUMO
Induction of type-IIA secreted phospholipase A2 (sPLA2-IIA) expression by bacterial components other than lipopolysaccharide has not been previously investigated. Here, we show that exposure of alveolar macrophages (AM) to Neisseria meningitidis or its lipooligosaccharide (LOS) induced sPLA2-IIA synthesis. However, N. meningitidis mutant devoid of LOS did not abolish this effect. In addition, a pili-defective mutant exhibited significantly lower capacity to stimulate sPLA2-IIA synthesis than the wild-type strain. Moreover, pili isolated from a LOS-defective strain induced sPLA2-IIA expression and nuclear factor kappa B (NF-kappaB) activation. These data suggest that pili are potent inducers of sPLA2-IIA expression by AM, through a NF-kappaB-dependent process.
Assuntos
Fímbrias Bacterianas/metabolismo , Lipopolissacarídeos/metabolismo , Macrófagos Alveolares/enzimologia , Neisseria meningitidis/citologia , Fosfolipases A/metabolismo , Animais , Fímbrias Bacterianas/química , Cobaias , Lipopolissacarídeos/isolamento & purificação , NF-kappa B/metabolismo , Neisseria meningitidis/genética , Neisseria meningitidis/metabolismo , Fosfolipases A/genética , Fosfolipases A2RESUMO
We analyzed 48 invasive isolates of Neisseria meningitidis that were isolated from meningitis cases in Burkina Faso (April 2002 to April 2003). Thirty-nine of these isolates had the phenotype (serogroup:serotype:serosubtype) W135:2a:P1.5,2, eight isolates were A:4:P1.9 and one isolate was nongroupable:nonserotypable:nonserosubtypable. Genotyping of meningococcal isolates showed that W135 isolates belonged to the sequence type (ST)-11. The nongroupable isolate was of genogroup W135 and belonged to ST-192. Isolates of serogroup A belonged to ST-2859 (a member of the subgroup III/ST-5 clonal complex). W135 (ST-11) isolates involved in meningitis outbreaks in Burkina Faso differed from those involved in the Hajj-2000 associated outbreak by their pulsed-field gel electrophoresis profile. These data confirm the changing epidemiology of meningococcal infection in Burkina Faso with the establishment and expansion of serogroup W135 N. meningitidis strains of the ET-37/ST-11 clonal complex, as well as the emergence of a new clone within the subgroup III/ST-5 clonal complex.
Assuntos
Doenças Transmissíveis Emergentes/epidemiologia , Meningite Meningocócica/epidemiologia , Neisseria meningitidis Sorogrupo W-135/classificação , Neisseria meningitidis Sorogrupo W-135/genética , Adolescente , Técnicas de Tipagem Bacteriana , Burkina Faso/epidemiologia , Criança , Pré-Escolar , Doenças Transmissíveis Emergentes/microbiologia , Feminino , Genótipo , Humanos , Lactente , Masculino , Meningite Meningocócica/microbiologia , Epidemiologia Molecular , Neisseria meningitidis Sorogrupo W-135/isolamento & purificação , Fenótipo , Vigilância da População , Estudos ProspectivosRESUMO
Neisseria meningitidis can cause asymptomatic carriage, followed by acquired immunity, or septicaemia, meningitis, septic arthritis or pericarditis. Vaccination induces protective bactericidal antibodies to invasive diseases. Meningococcal capsular polysaccharides are immunoprotective antigens from which vaccines are produced against serogroups A, C, Y and W135, including conjugate vaccines against serogroup C. There is no available vaccine against serogroup B, but outermembrane protein-based vaccines against this serogroup are currently being evaluated. Polysaccharide meningococcal vaccines are effective, but their strictly serogroup-specific efficacy raises concerns about the possible selection of escape variants. Therefore, meningococcal polysaccharide vaccines, either plain or conjugated, are indicated against the clonal expansion of strains whose serogroup has been properly identified and corresponds to the vaccine valence.
Assuntos
Infecções Meningocócicas/prevenção & controle , Vacinas Meningocócicas/uso terapêutico , Humanos , Infecções Meningocócicas/imunologia , Infecções Meningocócicas/microbiologiaRESUMO
Infections due to Neisseria meningitidis are a major public health concern. In France, during 1999-2002, a total of 2167 clinical isolates of N. meningitidis from invasive infections were studied at the National Reference Center for Meningococci (Paris). Serogroup B strains were the most common (58%), followed by serogroup C strains (29%) and serogroup W135 strains (8%). Various phenotypes were observed, reflecting heterogeneity in the meningococcal population. Strains were susceptible to antibiotics currently used for treatment and chemoprophylaxis of meningococcal infections. However, the prevalence of meningococci with reduced susceptibility to penicillin is increasing. Such strains were heterogeneous and accounted for approximately 30% of isolates during this period, warranting continued surveillance of this phenomenon.
Assuntos
Antibacterianos/farmacologia , Neisseria meningitidis/efeitos dos fármacos , Penicilina G/farmacologia , Resistência às Penicilinas/genética , Fenótipo , Farmacorresistência Bacteriana , França , Humanos , Meningite Meningocócica , Testes de Sensibilidade Microbiana , Neisseria meningitidis/genética , SorotipagemRESUMO
The clinical presentations of meningococcal diseases other than meningitis or meningococcemia may lead to erroneous diagnosis. Although several reports have described unusual meningococcal diseases, the Neisseria meningitidis strains involved in these forms have been poorly characterized. In this study, meningococcal arthritis and pericarditis were confirmed by isolation of N. meningitidis and/or detection of meningococcal DNA in synovial or pericardial fluid, respectively, and meningococcal pneumonia was detected by isolation of N. meningitidis from blood. From 1999 through 2002, meningococcal disease was bacteriologically confirmed in 26 cases of arthritis, 6 cases of pericarditis, and 33 cases of pneumonia by the National Reference Center for the Meningococci in Paris. We found a statistically significant association between strains of serogroup W135, mostly of the clonal complex ET-37, and arthritis. Pneumonia was most frequently diagnosed in patients aged >70 years, and 54.5% of the strains belonged to serogroup W135, although these strains had heterogeneous phenotypes. Bacteremia is a key step in the pathophysiology of meningococcal disease and precedes any form of invasive infection.
Assuntos
Artrite Infecciosa/microbiologia , Infecções Meningocócicas/microbiologia , Neisseria meningitidis/isolamento & purificação , Pericardite/microbiologia , Pneumonia/microbiologia , Adolescente , Adulto , Idoso , Técnicas Bacteriológicas , França , Humanos , Masculino , Pessoa de Meia-Idade , Neisseria meningitidis/classificação , SorotipagemRESUMO
The lpxA gene is known to be involved in the biosynthesis of lipid A in Gram-negative bacteria and thought to be an essential gene. However, viable meningococcal lpxA mutants devoid of detectable endotoxin (lipooligosaccharide) have been reported. We characterised such mutants in strains of Neisseria meningitidis belonging to serogroups B and C using molecular and biochemical analysis. While lpxA mutants with no detectable or a low level of lipooligosaccharide could be obtained in N. meningitidis, the simple insertional inactivation of lpxA was not possible. In all mutants, we obtained lpxA/lpxA::aph-3' heterodiploids harbouring one copy of the wild-type lpxA gene and one copy of the inactivated lpxA gene by insertion of the kanamycin resistance cassette, aph-3'. The absence of lipooligosaccharide in these mutants may result from a negative transdominance effect of a truncated LpxA protein on the wild-type LpxA protein.
Assuntos
Genes Bacterianos/genética , Lipídeo A/biossíntese , Mutagênese Insercional , Neisseria meningitidis/genética , Neisseria meningitidis/metabolismo , Southwestern Blotting , Carboidratos Epimerases/genética , Cromatografia Gasosa , Eletroforese em Gel de Poliacrilamida , Duplicação Gênica , Ordem dos Genes , Genes Essenciais/genética , Resistência a Canamicina/genética , Lipopolissacarídeos/análise , Lipopolissacarídeos/metabolismo , Reação em Cadeia da PolimeraseRESUMO
We developed a model of sequential influenza A virus (IAV)-Neisseria meningitidis serogroup C (Nm) infection in BALB/c mice. Mice infected intranasally with a sublethal IAV dose (260 pfu) were superinfected intranasally with Nm. Fatal meningococcal pneumonia and bacteremia were observed in IAV-infected mice superinfected with Nm on day 7, but not in those superinfected on day 10. The susceptibility of mice to Nm superinfection was correlated with the peak interferon-gamma production in the lungs and decrease in IAV load. After Nm challenge, both IAV-infected and uninfected control mice produced the inflammatory cytokines interleukin (IL)-1 and IL-6. However, IL-10 was detected in susceptible mice superinfected on day 7 after IAV infection, but not in resistant mice. This model of dual IAV-Nm infection was also used to evaluate the role of bacterial virulence factors in the synthesis of the capsule. A capsule-defective mutant was cleared from the lungs, whereas a mutant inactivated for the crgA gene, negatively regulating expression of the pili and capsule, upon contact with host cells, retained invasiveness. Therefore, this model of meningococcal disease in adult mice reproduces the pathogenesis of human meningococcemia with fatal sepsis, and is useful for analyzing known or new genes identified in genomic studies.
Assuntos
Vírus da Influenza A , Infecções Meningocócicas/virologia , Neisseria meningitidis , Infecções por Orthomyxoviridae/complicações , Pneumonia Bacteriana/virologia , Animais , Bacteriemia/imunologia , Bacteriemia/patologia , Bacteriemia/virologia , Citocinas/sangue , Modelos Animais de Doenças , Feminino , Infecções Meningocócicas/imunologia , Infecções Meningocócicas/patologia , Camundongos , Camundongos Endogâmicos BALB C , Neisseria meningitidis/patogenicidade , Infecções por Orthomyxoviridae/imunologia , Infecções por Orthomyxoviridae/patologia , Pneumonia Bacteriana/imunologia , Pneumonia Bacteriana/patologia , Pneumonia Viral/complicações , Pneumonia Viral/imunologia , Pneumonia Viral/patologia , Superinfecção/microbiologia , Superinfecção/patologia , Superinfecção/virologia , VirulênciaRESUMO
Anti-infective antibody-based immunotherapy has gained renewed interest since the crisis of antibiotic resistance and because there is no therapy against various viral infections. The immunoprophylaxis of respiratory infections aims to utilize the ability of local antibodies to neutralize inhaled micro-organisms and their cytopathic products. Immunoglobulins for intravenous use (i.v.i.g.) have a wide spectrum of specificities. Hyperimmune i.v.i.g. containing high titers of specific antibodies have demonstrated efficacy in clinical trials, notably against the respiratory syncytial virus. Monoclonal antibodies have the advantage to be homogenous and specific for one selected epitope and several studies have demonstrated their efficacy to neutralize several infectious agents. Moreover, antibodies can be administered topically and are effective at lower doses than those needed for systemic administration. The mechanism of action could be the agglutination of bacteria or viruses at the epithelial surfaces of the respiratory tract inhibiting the early steps of the infectious process. Thanks to new technologies of humanized monoclonal antibodies, immunotherapy offers real promising perspectives for prophylactic and therapeutic therapies against a variety of current or emerging infectious diseases.